Orladeyo
Payments companies reported to CMS as associated with Orladeyo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Orladeyo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Orladeyo
These are the largest totals companies reported as associated with Orladeyo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Raffi Tachdjian | Santa Monica, CA | Allergy & Immunology | $167,352.51 |
| William Lumry | Dallas, TX | $115,316.16 | |
| Patricia Stewart | Madison, MS | Allergy & Immunology | $109,831.50 |
| Michael Manning | Scottsdale, AZ | Allergy & Immunology | $63,193.49 |
| Daniel Soteres | Colorado Springs, CO | Allergy | $57,058.77 |
| Huamin Li | Wheaton, MD | Allergy | $51,520.37 |
| David Kaufman | Shreveport, LA | Allergy & Immunology | $49,975.56 |
| Rafael Zaragoza Urdaz | San Juan, PR | Allergy | $48,907.58 |
| Jeffrey Rumbyrt | Lakewood, CO | Allergy & Immunology | $47,400.91 |
| Jay Kashkin | Fair Lawn, NJ | Allergy | $35,507.32 |
Prescribed Orladeyo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.